Technologies On The Shelf
The Problem: The development of a biomarker for hypoxic tissues is essential both for diagnostic formulation and treatment planning for…Read More
The Problem: Most optical-physiological diagnoses are based on the insertion of light, with known parameters, to a tested tissue, followed…Read More
An Interactive Gaze Contingent System for the Diagnosis and Treatment of Social Communication and Attention Deficits in Infants and Children
The Problem: Over the last two decades a dramatic increase in the prevalence of socio-communicative disorders and attention disorders was…Read More
The Problem: Cancer detection is currently based on two insufficient imaging techniques: structural and functional. While structural techniques identify anatomic…Read More
BIRAD grants exclusive and non-exclusive licenses for the commercialization of BIU-based research findings, both to established companies and to new startup ventures established around University technology.
The licenses are granted for specific patents and/or know-how and are limited to a specific field and/or specific products. Licenses include diligence milestones for the development and sale of products covered by the license – to avoid technology "shelving" – and typically include a combination of the following forms of consideration: royalties, milestone payments, upfront fees, equity and/or annual license fees.